Mahindra & Mahindra's Thar ROXX records 1.76 lakh booking within 60 mins

Mahindra & Mahindra's Thar ROXX records 1.76 lakh booking within 60 mins


Mahindra & Mahindra announced that the newly launched Thar ROXX has registered 176218 bookings within 60 minutes of booking commencement at 11.00 am.

The unprecedented response reflects the broad appeal of Thar ROXX, captivating customers nationwide. With its head-turning design, refined driving experience, powerful performance, unmatched off-roading capability, top-tier safety features, spacious interiors, and advanced technology, Thar ROXX continues to set new benchmarks as a category disruptor in the SUV segment.

Click here to connect with us on WhatsApp

Deliveries of the Thar ROXX will commence on the auspicious occasion of Dussehra. Mahindra is grateful to its customers for the enthusiastic response and remains committed to prioritizing a seamless delivery experience. As deliveries begin, Mahindra will inform customers about their tentative delivery schedules in a phased manner over the next three weeks.

 

Powered by Capital Market – Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

First Published: Oct 03 2024 | 5:14 PM IST



Source link

Mahindra & Mahindra's Thar ROXX records 1.76 lakh booking within 60 mins

Shilpa Medicare announces receipt of CEP from EDQM for API 'Desmopressin'


Shilpa Medicare’s 100% subsidiary, Shilpa Pharma Lifesciences received certificate of suitability (CEP) from EDQM (European Directorate for the Quality of Medicines & Healthcare) for API, Desmopressin.

Desmopressin is synthetic peptide manufactured by Shilpa Pharma Lifesciences through solid phase synthesis. Desmopressin helps to reduce frequent urination and excessive thirst. This is used to treat central diabetes insipidus and bedwetting.

Click here to connect with us on WhatsApp

Powered by Capital Market – Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

First Published: Oct 03 2024 | 5:12 PM IST



Source link

Mahindra & Mahindra's Thar ROXX records 1.76 lakh booking within 60 mins

INR slumps near 84 per US dollar mark as local stock indices lose more than 2%


Indian Rupee slumped today, adding to recent string of losses amid a hefty correction in local stock markets. INR currently quotes at 83.97, down 14 paise on the day against the US dollar. US dollar index broke above 101 mark as a recovery from 14 month lows stayed in place. Geopolitical scenario remained tense globally. US dollar index stayed supported amid this and currently quotes up 0.25% at 101.68. US dollar index is at three week high right now. Local stock market indices saw deep losses on Thursday, affected by declines across most sectors. New SEBI regulations for the F&O segment have raised concerns, dragging both NIFTY50 and SENSEX down by more than 2%.

Powered by Capital Market – Live News

 

Click here to connect with us on WhatsApp

Disclaimer: No Business Standard Journalist was involved in creation of this content

First Published: Oct 03 2024 | 4:04 PM IST



Source link

Here's why Blue Star share price dropped 3% on October 3; details here

Here's why Blue Star share price dropped 3% on October 3; details here


Blue Star share price: Air conditioner (AC) manufacturer Blue Star share price fell as much as 2.83 per cent to hit an intraday low of Rs 2,039.05 per share on October 3, 2024. 


The drop in the share price of the air conditioner maker came after Oman-based WJ Towell & Co LLC increased the claim to Rs 461.74 crore (earlier Rs 223.60 crore) of its ongoing arbitration proceedings at the International Chamber of Commerce (ICC).

Click here to connect with us on WhatsApp


In an exchange filing, Blue Star said, “The company would like to intimate that while the arbitration proceedings filed against the company with the ICC was for OMR 103,18,000 (approx. Rs 223.60 crore) plus interest at 7 per cent on the total claim amount, the Statement of claim filed by WJT stands at OMR 2,11,80,748 (approx. Rs 461.74 crore).”

 


Earlier this year in April, WJ Towell & Co LLC (WJT) filed arbitration proceedings against Blue Star with International Chamber of Commerce (ICC) claiming OMR 103,18,000 (approximately Rs 223.6 crore) plus an interest of 7 per cent on the total claim amount, the company revealed.


“The company reiterates that the claims filed by WJT are frivolous, unsubstantiated, premised on fundamental factual misstatements and contrary to the overwhelming facts and evidence,” Blue Star said.


The claims made by WJT will not have any material financial impact on it, the company said based on its assessment.


Blue Star and WJ Towell & Co LLC (WJT) had entered into a shareholders’ agreement on October 1, 2015 for managing affairs of Blue Star Oman Electro Mechanical Company.


Blue Star is a leading manufacturer specialising in air purifiers, air coolers, water purifiers, cold storage, and specialty products. 


The company offers comprehensive turnkey solutions in MEP (Mechanical, Electrical, Plumbing, and Fire-fighting) projects, establishing itself as the largest after-sales service provider for air conditioning and commercial refrigeration in India. 


Its diverse business segments include Electro-Mechanical Projects, where it handles large-scale AC and ventilation installations, and Commercial Air Conditioning, where it leads in Conventional and Inverter Ducted Systems. Additionally, Blue Star’s unitary products range from air conditioning systems to water purifiers, available through a vast network of over 8,800 outlets across 650 locations.


The company’s clientele include Nippon, Ola Electric Mobility, and Wells Fargo. With a major global presence, Blue Star exports HVACR products to 18 countries in the Middle East, Africa, SAARC, and ASEAN regions. It has also expanded its reach through joint ventures in Qatar and Malaysia, focusing on MEP projects across residential, commercial, and infrastructure sectors. 


At 1:51 PM, shares of Blue Star were trading 0.41 per cent lower at Rs 2,090 per share. In comparison, BSE Sensex was down 2.03 per cent at 82,559.80 levels.

First Published: Oct 03 2024 | 2:01 PM IST



Source link

Jubilant Ingrevia hits 52-wk high as arm inks pact with leading agrochem co

Jubilant Ingrevia hits 52-wk high as arm inks pact with leading agrochem co


Jubilant Ingrevia share price


The stock surged after the specialty chemicals company announced that its subsidiary has inked a pact with a leading agrochemical company. to produce and supply it with an agro-intermediate for one of its key agro chemical products.

Click here to connect with us on WhatsApp


At around 11:49 AM, shares of Jubilant Ingrevia were up 7.38 per cent, at Rs 832.4 per share on the BSE. In comparison, the BSE Sensex was trading 1.48 per cent lower at 83,021.85 around the same time.

 


“We wish to inform you that Jubilant Agro Sciences, a wholly owned subsidiary of the company, has entered into an agreement with a leading Agrochemical Company to produce an Agro Intermediate for one of the key Agro actives of the customer,” the company’s exchange filing stated.


The filing added that the overall consideration will be paid based on the revenue of more than $300 million in the next few years after the commencement of production. Jubilant Agro Sciences will invest in the manufacturing facility to supply the agro intermediate to the customer.


As per Jubilant Ingrevia, the customer is a multi billion dollar company. Other details of the company were not revealed in Jubilant’s exchange filing.


Domestic brokerage Nuvama had recently raised its target price on Jubilant Ingrevia to Rs 849, from Rs 762 per share, along with retaining its ‘Buy’ rating on the company.


The brokerage expects Jubilant’s earnings before interest, tax, depreciation and amortisation (Ebitda) contribution from its speciality chemicals business to grow from 48 per cent in FY24 to 65 per cent by FY27.


“A likely recovery in the agrochemicals sector, combined with early progress in the diketene business shall drive margins,” the report stated. 

Further, analysts at the brokerage expect the company to grow in the speciality chemicals segment, as it is already in advanced discussions with customers across the agrochemical, pharmaceutical and semiconductor industries regarding potential custom development and manufacturing (CDMO) opportunities for long-term tie-ups. READ MORE


In the past one year, shares of Jubilant Ingrevia have gained 61.4 per cent, compared to the BSE Sensex’s rise of 29 per cent during the same period.

First Published: Oct 03 2024 | 1:15 PM IST



Source link

YouTube
Instagram
WhatsApp